Breast (Apr 2021)

Phase II neoadjuvant trial of Albumin-Bound Paclitaxel, Trastuzumab and Pertuzumab followed by anthracycline based regimens in patients with operable Her2 positive breast cancer (OMC-BC05)

  • M. Iwamoto,
  • A. Matsutani,
  • A. Ikari,
  • T. Tominaga,
  • S. Maezawa,
  • H. Oku,
  • K. Kimura

Journal volume & issue
Vol. 56
p. S52

Abstract

Read online

No abstracts available.